Evidence map›Paper›PMID 34552489›Full record

ReviewFrontiers in pharmacology2021

Natural Compounds With Antimicrobial and Antiviral Effect and Nanocarriers Used for Their Transportation.

Diana Stan, Ana-Maria Enciu, Andreea Lorena Mateescu, Andreea Cristina Ion, Ariana Cristina Brezeanu, Dana Stan, Cristiana Tanase

Abstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 115 papers.

0numbers the graph read from it
0cells of the map it votes in
115citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

115 citing papers in PubMed.

  1. Trial
  2. Antibacterial, Synergistic, and Antibiofilm Activities ofAntibiotics (Basel, Switzerland) · 2026
    Article
  3. Chemistry and Biological Activity of 11Molecules (Basel, Switzerland) · 2026
    Review
  4. Antibacterial and Immunomodulatory Effects ofInternational journal of molecular sciences · 2026
    Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Green synthesis of zinc oxide nanoparticles usingParasite epidemiology and control · 2026
    Article
  18. Antimicrobial and anti-inflammatory properties ofMicrobiology (Reading, England) · 2026
    Article
  19. Article
  20. Article

55 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Diana StanDDS Diagnostic, Bucharest, Romania.
Ana-Maria EnciuVictor Babes National Institute of Pathology, Biochemistry-Proteomics Department, Bucharest, Romania.
Andreea Lorena MateescuDDS Diagnostic, Bucharest, Romania.
Andreea Cristina IonDDS Diagnostic, Bucharest, Romania.
Ariana Cristina BrezeanuCarol Davila University of Medicine and Pharmacy-Department of Plastic Surgery, Bucharest, Romania.
Dana StanDDS Diagnostic, Bucharest, Romania.
Cristiana TanaseVictor Babes National Institute of Pathology, Biochemistry-Proteomics Department, Bucharest, Romania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Due to the increasing prevalence of life-threatening bacterial, fungal and viral infections and the ability of these human pathogens to develop resistance to current treatment strategies, there is a great need to find and develop new compunds to combat them. These molecules must have low toxicity, specific activity and high bioavailability. The most suitable compounds for this task are usually derived from natural sources (animal, plant or even microbial). In this review article, the latest and most promising natural compounds used to combat bacteria, filamentous fungi and viruses are presented and evaluated. These include plant extracts, essential oils, small antimicrobial peptides of animal origin, bacteriocins and various groups of plant compounds (triterpenoids; alkaloids; phenols; flavonoids) with antimicrobial and antiviral activity. Data are presented on the inhibitory activity of each natural antimicrobial substance and on the putative mechanism of action against bacterial and fungal strains. The results show that among the bioactive compounds studied, triterpenoids have significant inhibitory activity against coronaviruses, but flavonoids have also been shown to inhibit SARS-COV-2. The last chapter is devoted to nanocarriers used to improve stability, bioavailability, cellular uptake/internalization, pharmacokinetic profile and reduce toxicity of natural compunds. There are a number of nanocarriers such as liposomes, drug delivery microemulsion systems, nanocapsules, solid lipid nanoparticles, polymeric micelles, dendrimers, etc. However, some of the recent studies have focused on the incorporation of natural substances with antimicrobial/antiviral activity into polymeric nanoparticles, niosomes and silver nanoparticles (which have been shown to have intrinsic antimicrobial activity). The natural antimicrobials isolated from animals and microorganisms have been shown to have good inhibitory effect on a range of pathogens, however the plants remain the most prolific source. Even if the majority of the studies for the biological activity evaluation are

Indexed as

antifungalantimicrobialantiviraldrug delivery systemsnanocarriersnatural molecules

Identifiers

PMID34552489
PMCPMC8450524

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.